Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact

Bone is the second most common site of metastasis in patients with thyroid cancer (TC) and dramatically impacts overall survival and quality of life with no definitive cure, yet there is no extensive study of the demographic and clinical risk factors in the recent literature. Data regarding 120,754...

Full description

Bibliographic Details
Main Authors: Zenat Ahmed Khired, Mohammad H. Hussein, Jessan A. Jishu, Ahmed A. Toreih, Aly A. M. Shaalan, Mohammed M. Ismail, Manal S. Fawzy, Eman A. Toraih
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/14/3557
_version_ 1797589990332432384
author Zenat Ahmed Khired
Mohammad H. Hussein
Jessan A. Jishu
Ahmed A. Toreih
Aly A. M. Shaalan
Mohammed M. Ismail
Manal S. Fawzy
Eman A. Toraih
author_facet Zenat Ahmed Khired
Mohammad H. Hussein
Jessan A. Jishu
Ahmed A. Toreih
Aly A. M. Shaalan
Mohammed M. Ismail
Manal S. Fawzy
Eman A. Toraih
author_sort Zenat Ahmed Khired
collection DOAJ
description Bone is the second most common site of metastasis in patients with thyroid cancer (TC) and dramatically impacts overall survival and quality of life with no definitive cure, yet there is no extensive study of the demographic and clinical risk factors in the recent literature. Data regarding 120,754 TC patients with bone metastasis were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate analyses were used to identify the risk factors of bone metastasis occurring in various histologies of TC. Cox regression was performed to analyze the influence of bone metastasis on overall survival. Hazard ratios were computed to analyze the association between bone metastasis and the primary outcomes. Of the 120,754 records collected from the SEER database from 2000 to 2019, 976 (0.8%) presented with bone metastasis, with occurrence being the greatest in patients of age ≥ 55 years (OR = 5.63, 95%CI = 4.72–6.71), males (OR = 2.60, 95%CI = 2.27–2.97), Blacks (OR = 2.38, 95%CI = 1.95–2.9) and Asian or Pacific Islanders (OR = 1.90, 95%CI = 1.58–2.27), and single marital status. TC patients presenting with bone metastasis (HR = 2.78, 95%CI = 2.34–3.3) or concurrent bone and brain metastases (HR = 1.62, 95%CI = 1.03–2.55) had a higher mortality risk. Older age, gender, race, and single marital status were associated with bone metastasis and poorer prognosis in TC patients at initial diagnosis. Understanding such risk factors can potentially assist clinicians in making early diagnoses and personalized treatment plans, as well as researchers in developing more therapeutic protocols.
first_indexed 2024-03-11T01:14:00Z
format Article
id doaj.art-d26cd059d81c42a98d1808f452d6256b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T01:14:00Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d26cd059d81c42a98d1808f452d6256b2023-11-18T18:40:45ZengMDPI AGCancers2072-66942023-07-011514355710.3390/cancers15143557Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment ImpactZenat Ahmed Khired0Mohammad H. Hussein1Jessan A. Jishu2Ahmed A. Toreih3Aly A. M. Shaalan4Mohammed M. Ismail5Manal S. Fawzy6Eman A. Toraih7Department of Surgery, College of Medicine, Jazan University, Jazan 45142, Saudi ArabiaDivision of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USASchool of Medicine, Tulane University, New Orleans, LA 70112, USADepartment of Orthopedic Surgery, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptDepartment of Anatomy, Faculty of Medicine, Jazan University, Jazan 45142, Saudi ArabiaDepartment of Anatomy, Faculty of Medicine, Northern Border University, Arar 91431, Saudi ArabiaDepartment of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptDivision of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USABone is the second most common site of metastasis in patients with thyroid cancer (TC) and dramatically impacts overall survival and quality of life with no definitive cure, yet there is no extensive study of the demographic and clinical risk factors in the recent literature. Data regarding 120,754 TC patients with bone metastasis were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate analyses were used to identify the risk factors of bone metastasis occurring in various histologies of TC. Cox regression was performed to analyze the influence of bone metastasis on overall survival. Hazard ratios were computed to analyze the association between bone metastasis and the primary outcomes. Of the 120,754 records collected from the SEER database from 2000 to 2019, 976 (0.8%) presented with bone metastasis, with occurrence being the greatest in patients of age ≥ 55 years (OR = 5.63, 95%CI = 4.72–6.71), males (OR = 2.60, 95%CI = 2.27–2.97), Blacks (OR = 2.38, 95%CI = 1.95–2.9) and Asian or Pacific Islanders (OR = 1.90, 95%CI = 1.58–2.27), and single marital status. TC patients presenting with bone metastasis (HR = 2.78, 95%CI = 2.34–3.3) or concurrent bone and brain metastases (HR = 1.62, 95%CI = 1.03–2.55) had a higher mortality risk. Older age, gender, race, and single marital status were associated with bone metastasis and poorer prognosis in TC patients at initial diagnosis. Understanding such risk factors can potentially assist clinicians in making early diagnoses and personalized treatment plans, as well as researchers in developing more therapeutic protocols.https://www.mdpi.com/2072-6694/15/14/3557thyroid cancerboneosseousmetastasisrisk factorSEER
spellingShingle Zenat Ahmed Khired
Mohammad H. Hussein
Jessan A. Jishu
Ahmed A. Toreih
Aly A. M. Shaalan
Mohammed M. Ismail
Manal S. Fawzy
Eman A. Toraih
Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
Cancers
thyroid cancer
bone
osseous
metastasis
risk factor
SEER
title Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
title_full Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
title_fullStr Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
title_full_unstemmed Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
title_short Osseous Metastases in Thyroid Cancer: Unveiling Risk Factors, Disease Outcomes, and Treatment Impact
title_sort osseous metastases in thyroid cancer unveiling risk factors disease outcomes and treatment impact
topic thyroid cancer
bone
osseous
metastasis
risk factor
SEER
url https://www.mdpi.com/2072-6694/15/14/3557
work_keys_str_mv AT zenatahmedkhired osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT mohammadhhussein osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT jessanajishu osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT ahmedatoreih osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT alyamshaalan osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT mohammedmismail osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT manalsfawzy osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact
AT emanatoraih osseousmetastasesinthyroidcancerunveilingriskfactorsdiseaseoutcomesandtreatmentimpact